cinacalcet has been researched along with Milk-Alkali Syndrome in 146 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 37 (25.34) | 29.6817 |
2010's | 81 (55.48) | 24.3611 |
2020's | 28 (19.18) | 2.80 |
Authors | Studies |
---|---|
Kaku, K; Kamei, S; Kaneto, H; Kimura, T; Kohara, K; Mune, T; Nakanishi, S; Obata, A; Sanada, J; Shimoda, M; Tatsumi, F | 1 |
Doumas, A; Goropoulos, A; Karras, S; Siolos, A; Terzaki, A; Tigas, S; Tzotzas, T; Zaramboukas, T | 1 |
Aindow, A; Isherwood, L; Mughal, MZ; Ramakrishnan, R; Wade, L | 1 |
Hao, Y; Ji, W; Lei, Z; Shi, N; Yu, L; Zhang, X | 1 |
Capuano, B; Conigrave, AD; Dinh, LV; Gregory, KJ; Josephs, TM; Keller, AN; Leach, K; Zhang, F | 1 |
Demir, S; Dilek, E; Gürkan, H; İnan, M; Kökenli, F; Özgüç Çömlek, F; Sezer, A | 1 |
Blanchard, C; Caillard, C; Figueres, L; Frey, S; Goronflot, T; Gourraud, PA; Hourmant, M; Kerleau, C; Mirallié, É; Wargny, M | 1 |
Cao, Y; Sun, H; Wang, Z; Xiong, Y | 1 |
Bibik, E; Dobreva, E; Eremkina, A; Gorbacheva, A; Krupinova, J; Mirnaya, S; Mokrysheva, N | 1 |
Maguire, D; Rasool, I; Shah, PM | 1 |
Dejkhamron, P; Intachai, W; Kantaputra, P; Ketudat Cairns, JR; Khorana, J; Ngamphiw, C; Olsen, B; Tongsima, S; Watcharachan, K; Wejaphikul, K | 1 |
Fung, MM; Lang, BH; Lui, DT; Tam, DS | 1 |
Ahmad, HM; Shafiq, MU; Shaukat, M | 1 |
Chen, H; Disharoon, M; Fazendin, J; Gillis, A; Lindeman, B; McLeod, MC; McMullin, JL; Ong, S; Price, G; Stidham, G; Wang, R | 1 |
Faiq, S; Hu, T; Ku, G; Lavelle, K; Shoback, D | 1 |
Ansori, ANM; Scappaticcio, L; Trimboli, P | 1 |
Koca, SB | 1 |
Denoncin, C; Godefroid, N; Limaye, N; Pirson, Y; Scheers, I; Sokal, E; Stephenne, X | 1 |
Barreto, FC; Bucharles, SGE; Riella, MC | 1 |
Hasegawa, M; Koike, J; Koitabashi, K; Shibagaki, Y; Suzuki, T; Uehara, A; Yamamoto, Y; Yazawa, M | 1 |
Bränström, R; Koman, A; Nilsson, IL; Ohlsson, S; Pernow, Y | 1 |
Bottoni, G; Foppiani, L; Piccardo, A | 1 |
Lopes de Lima, M; Mazzali, M; Rivelli, GG | 1 |
Aschenbach, R; Biermann, A; Freesmeyer, M; Kloos, C; Lupp, A; Mtuka-Pardon, G; Seifert, P; Werner, C; Wolf, G | 1 |
Bestard, O; Codina, S; Coloma, A; Cruzado, JM; Francos, J; García-Barrasa, A; Manonelles, A; Melilli, E; Montero, N; Moreno, P; Torregrosa, JV | 1 |
Jatoi, A; Loprinzi, CL; Onitilo, AA; Sheehan, MT; Wermers, RA | 1 |
Bränström, R; Koman, A; Nilsson, IL; Pernow, Y | 1 |
Bayliss, AL; Codner, G; Gorvin, CM; Hannan, FM; Kooblall, KG; Stevenson, M; Stewart, M; Stokes, VJ; Teboul, L; Thakker, RV; Wells, S | 1 |
Alfadhli, EM | 1 |
Bailey, M; Manners, R; McDougall, C; Timmons, JG | 1 |
Bachmeyer, C; Belaube, N; Gauthé, M; Haymann, JP; Loi, V; Wendum, D | 1 |
Abdelmoneim, SS; Gopinath, C; Pattan, V; Singh, B; Sundaresh, V | 1 |
Misiorowski, W; Zgliczyński, W | 1 |
Biain Ciganda, A; Bustinza Beaskoetxea, Z; Fernández Matia, G; Gonzalo García, I; Martín Macías, MLA; Martínez Guisasola, J; Robles Fradejas, M; Ruiz Pérez, E | 1 |
Brown, SD; Cox, RD; Gorvin, CM; Hannan, FM; Hough, TA; Howles, SA; Nesbit, MA; Paudyal, A; Piret, SE; Stewart, M; Thakker, RV; Wells, S | 1 |
Fyssa, L; Goumenos, DS; Ntrinias, T; Papachristou, E; Papasotiriou, M; Savvidaki, E; Zavvos, V | 1 |
Kapczynski, A; Kim, J; Ross, JS | 1 |
Ohno, Y; Oshima, J; Otsuka, K | 1 |
Breitwieser, GE; Gorvin, CM; Hannan, FM; Krishnamurthy, SB; Metpally, R; Overton, JD; Reid, JG; Stokes, VJ; Thakker, RV | 1 |
Ago, T; Arakawa, S; Kimura, S; Kitazono, T; Ohya, Y; Osaki, M; Sakai, S; Yasuda, C | 1 |
Bellasi, A; Cancarini, G; Cozzolino, M; Esposito, C; Genderini, A; Guastoni, CM; Locatelli, F; Malberti, F; Messa, P; Ondei, P; Pontoriero, G; Teatini, U; Vezzoli, G | 1 |
Arif, H; Babich, M; Beg, M; Christou, A; Sial, M; Talwar, A; Zahid, S | 1 |
Carda, S; Da Costa F de Frias Pinto, A; Grana, E | 1 |
Cetani, F; Ferrari, F; Marcocci, C | 1 |
Cetani, F; Marcocci, C; Saponaro, F | 1 |
Ando, T; Iiri, T; Kawakami, A; Kikuchi, Y; Makita, N; Manaka, K; Matsumoto, N; Mitani, K; Nangaku, M; Niwa, T; Ogawa, T; Ootaki, M; Sato, J; Takeba, Y | 1 |
Alexander, RT; Beggs, MR; Chen, XZ; Dimke, H; Flockerzi, V; Lee, JJ; Liu, X; O'Neill, D; Weissgerber, P | 1 |
Fujita, M; Iiri, T; Ito, N; Kinoshita, Y; Makita, N; Manaka, K; Nangaku, M; Sato, J | 1 |
Han, KH; Han, SY; Jo, HA; Jun, H; So, YK | 1 |
Borchhardt, K; Cohen, G; Hörl, WH; Raupachova, J | 1 |
Colloton, M; Henley, C; Martin, D; Scully, S; Shatzen, E; Starnes, C; Wiemann, B | 1 |
Domínguez Quintero, ML; Ferrer Castillo, MT; García Soblechero, E; González Fuentes, C; Jiménez Crespo, B | 1 |
Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; London, GM; Mahaffey, KW; Modafferi, DM; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC | 1 |
Ogrin, C | 1 |
Barros, X; Torregrosa, JV | 1 |
Bravo, J; Crespo, J; Díaz, JM; García, MR; Gentil, MÁ; Gómez Alamillo, C; Gómez, G; Gutiérrez Dalmau, A; Jiménez, VL; Jimeno, L; Morales, E; Rodríguez Benot, A; Romero, R; Sáez, MJ; Torregrosa, JV | 1 |
Drake, WM; Hanson, PL; Jones, P; Pittaway, JF; Srirangalingam, U | 1 |
Buonomano, P; Circelli, L; Colao, A; Del Prete, M; Di Somma, C; Faggiano, A; Marciello, F; Marotta, V; Modica, R; Ramundo, V; Rubino, M; Sciammarella, C; Vitale, M | 1 |
Barros, X; Fuster, D; Oppenheimer, F; Paschoalin, R; Perlaza, P; Pons, F; Rubello, D; Torregrosa, JV | 1 |
Cooper, K; Deng, H; Evenepoel, P; Holdaas, H; Messa, P; Mourad, G; Olgaard, K; Rutkowski, B; Schaefer, H; Torregrosa, JV; Wuthrich, RP; Yue, S | 1 |
Baorda, F; Campo, MR; Cignarelli, M; Cinque, L; Conserva, A; Guarnieri, V; Lamacchia, O; Mastromatteo, E; Scillitani, A | 1 |
Dochez, V; Ducarme, G | 1 |
Crouzeix, G; Kerlan, V | 1 |
Armanini, D; Bordin, L; Camozzi, V; Donà, G; Iacobone, M; Mian, C; Sabbadin, C | 1 |
Bilezikian, J; Bone, H; Gurevich, A; Khan, A; Lakatos, P; Misiorowski, W; Rozhinskaya, L; Tóth, M; Trotman, ML | 1 |
Brardi, S; Cevenini, G; Ponchietti, R; Romano, G; Verdacchi, T | 1 |
Borchhardt, K; Gessl, A; Thiem, U | 1 |
Canaff, L; Cole, DE; Hendy, GN; Lee, BS; Mäkitie, O; Tenhola, S; Välimäki, MJ; Valta, H; Wong, BY | 1 |
Bestard, O; Cruzado, JM; Francos, J; García-Barrasa, A; Gómez-Vaquero, C; Grinyó, JM; Mast, R; Moreno, P; Polo, C; Revuelta, I; Taco, O; Torras, J; Torregrosa, JV | 1 |
Drüeke, TB; Fukagawa, M | 1 |
Babinsky, VN; Gorvin, CM; Hannan, FM; Hanyaloglu, AC; Howles, SA; Hu, J; Nesbit, MA; Rust, N; Spiegel, AM; Thakker, RV | 1 |
Babinsky, VN; Gorvin, CM; Hannan, FM; Howles, SA; McKenna, MJ; Nesbit, MA; Richardson, T; Rogers, A; Rust, N; Thakker, RV | 1 |
Durlik, M; Gałązka, Z; Ważna-Jabłońska, E | 1 |
Alsaygh, N; Bartlett, AM; Luttrell, L; Mathews, JW; Winchester, R | 1 |
Katagiri, M; Miura, D; Nakashima, N; Ohishi, H; Shimazaki, R; Takahashi, S; Takeuchi, Y; Tominaga, Y | 1 |
Aitken, E; Al-Moasseb, Z | 1 |
Bahner, U; Brandl, M; Nies, C; Schmidt-Gayk, H | 1 |
Cointault, O; Durand, D; Esposito, L; Gandia, P; Gennero, I; Guitard, J; Kamar, N; Lavayssière, L; Rostaing, L; Spataru, L | 1 |
Akinci, B; Comlekci, A; Tankurt, E | 1 |
Clark, OH; Evenepoel, P; Triponez, F; Vanrenthergem, Y | 1 |
Kebig, A; Mohr, K | 1 |
Bergua, C; Campistol, JM; Fuster, D; Gutierrez-Dalmau, A; Oppenheimer, F; Torregrosa, JV | 1 |
Bjerknes, R; Netelenbos, C; Raeder, H; Shaw, N | 1 |
Borchhardt, KA; Haas, M; Heinzl, H; Hörl, WH; Mayerwöger, E; Sunder-Plassmann, G | 1 |
Bos, WJ; Bouman, K; Braun, J; Brink, H; Carter, D; Frazão, JM; Graf, H; Macário, F; Maduell, F; Messa, P; Pontoriero, G; Reichel, H; Saha, H; Torregrosa, V; von Albertini, B; Wilkie, M; Yaqoob, M; Zani, VJ | 1 |
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B | 1 |
de Boer, H; Groot, I; Hermus, A; Horjus, C; Kovacs, CS; Telting, D; van Setten, P; van Sorge, A | 1 |
Shaw, NJ; Stanley, S | 1 |
de Francisco, AL; Piñera, C | 1 |
Adam, MA; Olson, JA; Untch, BR | 1 |
Shaheen, FA; Souqiyyeh, MZ | 1 |
Błazejewska, A; Flisiński, M; Manitius, J; Pypkowski, J | 1 |
Padmanabhan, H | 1 |
Abdellatif, A; Fanari, Z; Haque, W; Kadikoy, H; Pacha, O | 1 |
Andres, A; Gutierrez, E; Morales, E | 1 |
Alon, US; VandeVoorde, RG | 1 |
Copley, JB; Germain, M; Katznelson, S; Pankewycz, O; Shah, T; Sprague, SM; Stern, L; Turner, SA; Wang, O | 1 |
Bilezikian, JP; Bolognese, MA; Borofsky, M; Cheng, S; Peacock, M; Scumpia, S; Shoback, D; Sterling, LR | 1 |
Aalten, J; Hoitsma, AJ; Wetzels, JF | 1 |
Chamberlain, CE; Cho, ME; Duan, Z; Mannon, RB; Reynolds, JC; Ring, MS | 1 |
Cuxart Pérez, M; Picazo Sánchez, M; Sans Lorman, R; Sardà Borroy, C | 1 |
Arranz Martín, A; Azcárate Villalón, A; Carraro, R; Gómez Pan, A; Luque Ramírez, M; Marazuela Azpíroz, M; Paniagua Ruiz, A; Santana Durán, B | 1 |
Pestana Vasconcelos, M; Pinho, LR; Ribeiro Santos, MJ | 1 |
Alfieri, C; Brezzi, B; Messa, P | 1 |
Colao, A; Coppola, A; Di Somma, C; Faggiano, A; Gasperi, M; Lombardi, G; Panico, F; Ramundo, V; Savastano, S; Severino, R; Vuolo, L | 1 |
Bravo Soto, J; Esteban de la Rosa, RJ; Fernández Castillo, R; Fernández Gallegos, R; Oliva, N; Vaquero, E | 1 |
Attaf, D; Boulanger, H; Flamant, M; Fouqueray, B; Glotz, D; Haymann, JP; Mansouri, R; Mercadal, L; Metivier, F | 1 |
Casanueva, FF; García López, JM; García Vázquez, M; Prieto Tenreiro, AM; Puñal Rodríguez, JA | 1 |
Banti, C; Cetani, F; Chiavistelli, S; Cianferotti, L; Marcocci, C; Pinchera, A; Saponaro, F; Viccica, G; Vignali, E | 1 |
Cifuentes, M; Mattar, P; Reyes, M; Rothe, HM; Shapiro, WB | 1 |
Abreu, C; Castro, JC; Díez, JJ; Iglesias, P | 1 |
Jacobs, L; Koek, HL; Samson, MM; Verhaar, HJ | 1 |
Youssef, D | 1 |
Amdahl, M; Cozzolino, M; Goldsmith, D; Ketteler, M; Khan, S; Martin, KJ; Marx, S; Sharma, A; Wolf, M | 1 |
Ferrer, J; Oriola, J; Torres Grajales, JL; Tundidor Rengel, D; Webb, SM | 1 |
Hong, L; Nance, M; Newton, H | 1 |
McCaffrey, P; Wallace, HJ; Wallace, IR | 1 |
Bellamy, J; Janklewicz, P; Rostoker, G | 1 |
Tominaga, Y | 1 |
Cai, MM; Holt, SG; McMahon, LP; Smith, ER; Williams, DS | 1 |
Barros, X; Campistol, JM; Durán, CE; Paschoalin, RP; Torregrosa, JV | 1 |
Barros, X; Campistol, JM; Durán, CE; Paschoalin, RP; Sánchez-Escuredo, A; Torregrosa, JV | 1 |
Franceschini, N; Joy, MS; Kshirsagar, A | 1 |
Drüeke, TB | 2 |
Marti, HP; Schwarz, AA; Serra, AL; Wick, FH; Wüthrich, RP | 1 |
Boulanger, H; Fouqueray, B; Glotz, D; Haymann, JP; Mansouri, R; Metivier, F; Sarfati, E | 1 |
Abbassi, A; Chuong, VT; de Vernejoul, MC; Guédon, C; Roueff, S; Saint Georges, M; Ureña Torres, P | 1 |
Apostolou, T; Damianou, L; Drakopoulos, S; Hadjiconstantinou, V; Kotsiev, V | 1 |
Torres, PU | 1 |
Blessios, G; Gundroo, A; Karam, J; Kohli, R; Laftavi, M; Leca, N; Min, I; Pankewycz, O; Sridhar, N; Venuto, R | 1 |
de Boer, H; Hamdy, NA; Hermus, AR; Karperien, M; Timmers, HJ | 1 |
Lang, B; Lo, CY | 1 |
Szmuilowicz, ED; Utiger, RD | 1 |
Bilezikian, JP; Silverberg, SJ | 1 |
Shelly, MA; Sloand, JA | 1 |
Bruns, DE; D'Amour, P; Hanks, JB; Henrich, LM; Levine, MA; Rogol, AD | 1 |
de Jong, GM; Gregoor, PS | 1 |
Prié, D | 1 |
Colin Forfar, J; Tilling, L | 1 |
Bilezikian, JP; Faiman, C; Klassen, P; Olson, KA; Peacock, M; Rubin, MR; Schwanauer, LE; Shoback, DM; Silverberg, SJ; Smallridge, RC | 1 |
Bucci, CM; Howard, RJ; Kaplan, B; Meier-Kriesche, HU; Schold, JD; Srinivas, TR; Womer, KL | 1 |
Festen-Spanjer, B; Haring, CM; Koster, JB; Mudde, AH | 1 |
Bergua, C; Cofán, F; Oppenheimer, F; Torregrosa, JV | 1 |
Fukagawa, M; Komaba, H | 1 |
Block, GA; Bushinsky, DA; Chertow, GM; Chi, EM; Sugihara, J; Turner, SA; Zeig, S | 1 |
23 review(s) available for cinacalcet and Milk-Alkali Syndrome
Article | Year |
---|---|
Effective long-term management of parathyromatosis-related refractory hypercalcemia with a combination of denosumab and cinacalcet treatment.
Topics: Bone Density; Cinacalcet; Denosumab; Humans; Hypercalcemia; Hyperparathyroidism; Male | 2022 |
Different treatment strategies in primary hyperparathyroidism during pregnancy.
Topics: Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Parathyroidectomy; Pregnancy; Pregnancy Complications | 2022 |
Cinacalcet therapy in a child with novel homozygous CASR p.Glu353Lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature.
Topics: Calcium; Child, Preschool; Cinacalcet; Humans; Hypercalcemia; Hypophosphatemia; Male; Mutation; Receptors, Calcium-Sensing | 2023 |
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic.
Topics: Bone Density; Calcium; Cinacalcet; COVID-19; Diphosphonates; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Parathyroidectomy; Raloxifene Hydrochloride; Vitamin D | 2021 |
Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus-a Case Report and Review of Literature.
Topics: Calcitonin; Calcium; Calcium-Regulating Hormones and Agents; Carcinoma, Squamous Cell; Cinacalcet; Drug Resistance; Endoscopy, Digestive System; Esophageal Neoplasms; Esophagus; Fatal Outcome; Humans; Hypercalcemia; Male; Middle Aged; Pamidronate; Positron-Emission Tomography | 2019 |
Non-surgical management of primary hyperparathyroidism.
Topics: Calcium; Cinacalcet; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Parathyroid Hormone; Parathyroidectomy; Pregnancy; Pregnancy Complications; Vitamin D Deficiency | 2018 |
Management of hypercalcemia after renal transplantation.
Topics: Algorithms; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Renal Dialysis; Vitamin D | 2013 |
Primary hyperparathyroidism during pregnancy.
Topics: Calcitonin; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperplasia; Naphthalenes; Parathyroid Neoplasms; Pregnancy; Pregnancy Complications | 2015 |
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Cushing Syndrome; Diphosphonates; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperthyroidism; Imidazoles; Male; Parathyroidectomy; Zoledronic Acid | 2015 |
Surgical treatment of persistent hyperparathyroidism after renal transplantation.
Topics: Cinacalcet; Cryopreservation; Diagnostic Imaging; Disease Progression; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Failure, Chronic; Kidney Transplantation; Monitoring, Intraoperative; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Thymectomy | 2008 |
[Cinacalcet - an allosteric enhancer at the Ca2+-receptor].
Topics: Calcium; Cinacalcet; Drug Monitoring; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Receptors, Calcium-Sensing; Renal Dialysis | 2008 |
Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.
Topics: Biopsy; Cinacalcet; Diagnostic Imaging; Gene Expression; Humans; Hypercalcemia; Hyperparathyroidism; Immunohistochemistry; Intraoperative Care; Monitoring, Physiologic; Mutation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Prognosis; Risk Factors; Tumor Suppressor Proteins | 2010 |
Medical management of primary hyperparathyroidism with concomitant multiple myeloma.
Topics: Cinacalcet; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Multiple Myeloma; Naphthalenes; Pancytopenia; Treatment Outcome | 2010 |
Treatment with calcimimetics in kidney transplantation.
Topics: Bone Diseases; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Transplantation; Minerals; Naphthalenes; Postoperative Complications; Survival Analysis; Vitamin D Deficiency | 2010 |
Clinical utilization of cinacalcet in hypercalcemic conditions.
Topics: Calcimimetic Agents; Cinacalcet; Clinical Trials as Topic; Drug Evaluation; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Receptors, Calcium-Sensing; Renal Dialysis | 2011 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. Parathyroidectomy for secondary hyperparathyroidism].
Topics: Chronic Disease; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Japan; Kidney Diseases; Naphthalenes; Parathyroidectomy; Practice Guidelines as Topic | 2012 |
Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism.
Topics: Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Receptors, Cell Surface | 2003 |
Calcimimetics versus vitamin D: what are their relative roles?
Topics: Calcitriol; Cinacalcet; Clinical Trials as Topic; Drug Synergism; Ergocalciferols; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Liver; Naphthalenes; Phosphates; Receptors, Calcitriol; Receptors, Calcium-Sensing; Vitamin D; Vitamin D Deficiency | 2004 |
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phosphates; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D | 2006 |
Parathyroid cancer.
Topics: Cinacalcet; Humans; Hypercalcemia; Intraoperative Period; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography | 2006 |
The diagnosis and management of asymptomatic primary hyperparathyroidism.
Topics: Bone Diseases; Cardiovascular Diseases; Cinacalcet; Diphosphonates; Estrogens; Gastrointestinal Diseases; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Glands; Phosphates; Renal Insufficiency | 2006 |
[Hypercalcemia (with treatment)].
Topics: Adrenal Cortex Hormones; Aged; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcitriol; Calcium; Cinacalcet; Creatinine; Densitometry; Diphosphonates; Emergencies; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Mutation; Naphthalenes; Parathyroid Hormone; Radionuclide Imaging; Receptors, Calcium-Sensing; Renal Insufficiency; Thyroid Hormones | 2006 |
[Basic and clinical aspects of calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation].
Topics: Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Naphthalenes; Postoperative Complications; Receptors, Calcium-Sensing | 2008 |
17 trial(s) available for cinacalcet and Milk-Alkali Syndrome
Article | Year |
---|---|
Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies | 2020 |
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
Topics: Adult; Aged; Bone Diseases, Metabolic; Calcimimetic Agents; Cinacalcet; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Proportional Hazards Models; Renal Dialysis; Severity of Illness Index | 2013 |
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism.
Topics: Adult; Bone Density; Bone Remodeling; Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Phosphorus; Placebos | 2014 |
Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery.
Topics: Adult; Aged; Aged, 80 and over; Cinacalcet; Contraindications; Double-Blind Method; Endpoint Determination; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Phosphorus | 2015 |
Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study.
Topics: Aged; Allopurinol; Calcimimetic Agents; Cinacalcet; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Nephrolithiasis; Pilot Projects; Potassium Citrate; Prospective Studies; Treatment Outcome | 2015 |
A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
Topics: Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Parathyroidectomy; Postoperative Complications; Prospective Studies | 2016 |
Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
Topics: Adult; Aged; Asian People; Calcium; Calcium, Dietary; Cinacalcet; Creatinine; Demography; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Vital Signs | 2017 |
Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone Density; Calcifediol; Calcitriol; Calcium; Cinacalcet; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Prospective Studies; Time Factors; Treatment Outcome | 2008 |
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.
Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D | 2009 |
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Analysis of Variance; Bone Density; Calcium; Cinacalcet; Double-Blind Method; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphates; Severity of Illness Index; Treatment Outcome | 2011 |
[Low-dose cinacalcet reduces serum calcium in patients with primary hyperparathyroidism not eligible for surgery].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Asthenia; Calcium; Cinacalcet; Contraindications; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Nausea; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Prospective Studies; Vitamin D | 2011 |
[Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation].
Topics: Adult; Biomarkers; Calcimimetic Agents; Cinacalcet; Collagen; Drug Administration Schedule; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptide Fragments; Treatment Outcome | 2012 |
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Bone Density; Bone Density Conservation Agents; Calcium; Cinacalcet; Drug Therapy, Combination; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Receptors, Calcitriol; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D | 2012 |
Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
Topics: Aged; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Prospective Studies | 2005 |
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Quality of Life; Treatment Outcome | 2007 |
Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism.
Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Patient Selection; Prospective Studies | 2007 |
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Severity of Illness Index; Sterols; Treatment Outcome; Vitamin D | 2008 |
106 other study(ies) available for cinacalcet and Milk-Alkali Syndrome
Article | Year |
---|---|
Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report.
Topics: Aged; Calcium-Regulating Hormones and Agents; Cinacalcet; Creatinine; Humans; Hypercalcemia; Male | 2021 |
Successful use of cinacalcet monotherapy in the management of siblings with homozygous calcium-sensing receptor mutation.
Topics: Calcium; Child; Cinacalcet; Homozygote; Humans; Hypercalcemia; Infant; Infant, Newborn; Mutation; Receptors, Calcium-Sensing; Siblings | 2022 |
Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in
Topics: Adult; Calcium; Calcium-Regulating Hormones and Agents; Cinacalcet; HEK293 Cells; Humans; Hypercalcemia; Male; Mutation; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Radiofrequency Ablation; Receptors, Calcium-Sensing; Treatment Failure | 2021 |
Personalised medicines for familial hypercalcemia and hyperparathyroidism.
Topics: Calcium; Cinacalcet; HEK293 Cells; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Mutation; Precision Medicine; Receptors, Calcium-Sensing | 2022 |
The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Male; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing | 2022 |
Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney; Kidney Transplantation; Parathyroid Hormone; Parathyroidectomy | 2022 |
Neurorescuing effect of Cinacalcet against hypercalcemia-induced nerve injury in chronic kidney disease via TRAF2/cIAP1/KLF2/SERPINA3 signal axis.
Topics: Animals; Cinacalcet; Hypercalcemia; Mice; Renal Insufficiency, Chronic; TNF Receptor-Associated Factor 2; Ubiquitin | 2023 |
Refractory paraneoplastic hypercalcaemia responding to cinacalcet.
Topics: Bone Neoplasms; Cinacalcet; Female; Humans; Hypercalcemia; Neoplasm Recurrence, Local; Parathyroid Hormone; Urinary Bladder Neoplasms | 2022 |
Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
Topics: Calcitriol; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hypoparathyroidism; Infant; Infant, Newborn; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing | 2023 |
Pre-operative Cinacalcet Administration Reduces Immediate Post-operative Hypocalcemia Following Total Parathyroidectomy in Severe Renal Hyperparathyroidism.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies; Treatment Outcome | 2023 |
Neonatal severe hyperparathyroidism: A case report.
Topics: Calcium; Child; Cinacalcet; Heterozygote; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Male; Mutation | 2022 |
Resolution of Secondary Hyperparathyroidism After Kidney Transplantation and the Effect on Graft Survival.
Topics: Calcium; Cinacalcet; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies | 2023 |
Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Male; Middle Aged; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Zoledronic Acid | 2023 |
Editorial: Cancer-related hypercalcemia and potential treatments.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Neoplasms | 2023 |
Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation.
Topics: Acute Disease; Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Adolescent; Calcium-Regulating Hormones and Agents; Cinacalcet; Female; Humans; Hypercalcemia; Mutation; Pancreatitis; Recurrence; Trypsin Inhibitor, Kazal Pancreatic | 2019 |
The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D | 2019 |
A Functional Parathyroid Cyst from the Hemorrhagic Degeneration of a Parathyroid Adenoma.
Topics: Adenoma; Aged; Calcimimetic Agents; Cinacalcet; Cysts; Humans; Hypercalcemia; Hyperparathyroidism; Male; Parathyroid Glands; Parathyroid Neoplasms; Parathyroidectomy; Treatment Outcome | 2020 |
Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy.
Topics: Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Pilot Projects; Postoperative Period; Quality of Life; Treatment Outcome | 2019 |
Primary Hyperparathyroidism Manifesting with Severe Hypercalcemia in a Nonagenarian Man: Pitfall of Common Imaging Techniques, Localization by 18F-Choline Positron Emission Tomography/Computed Tomography and Successful Management with Calcimimetics.
Topics: Aged, 80 and over; Calcimimetic Agents; Choline; Cinacalcet; Fluorine Radioisotopes; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Severity of Illness Index | 2019 |
Safety and Efficacy of a 3-Year Therapy With Cinacalcet in Persistent Hyperparathyroidism After Renal Transplant.
Topics: Adult; Calcium; Cinacalcet; Drug Administration Schedule; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Postoperative Complications; Retrospective Studies; Time Factors; Treatment Outcome | 2020 |
Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet.
Topics: Adenoma; Biopsy; Calcium-Regulating Hormones and Agents; Cinacalcet; Cysts; Diagnostic Errors; Disease Progression; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Magnetic Resonance Imaging; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Thyroid Diseases; Tumor Burden; Ultrasonography | 2020 |
Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy.
Topics: Bone Density Conservation Agents; Calcitonin; Calcium; Cinacalcet; Humans; Hypercalcemia | 2020 |
Prediction of cognitive response to surgery in elderly patients with primary hyperparathyroidism.
Topics: Adult; Aged; Calcimimetic Agents; Cinacalcet; Cognitive Dysfunction; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroidectomy; Prospective Studies; Treatment Outcome | 2021 |
Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2.
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Animals; Bone Density; Calcium; Cinacalcet; CRISPR-Cas Systems; Disease Models, Animal; Fibroblast Growth Factor-23; Gene Editing; Humans; Hypercalcemia; Mice; Mutation; Phenotype; Receptors, Calcium-Sensing | 2021 |
Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism.
Topics: Aged; Calcium; Cinacalcet; Cognitive Dysfunction; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Hormone | 2021 |
Hypercalcemia and Acute Renal Failure Indicating Peritoneal Sarcoidosis.
Topics: Acute Kidney Injury; Aged, 80 and over; Calcium-Regulating Hormones and Agents; Cinacalcet; Diagnosis, Differential; Glucocorticoids; Humans; Hypercalcemia; Laparoscopy; Lymphadenopathy; Male; Peritoneal Diseases; Peritonitis, Tuberculous; Positron Emission Tomography Computed Tomography; Prednisone; Renal Insufficiency, Chronic; Sarcoidosis; Tomography, X-Ray Computed | 2021 |
Lithium-Induced Hyperparathyroidism: An Ill-defined Territory.
Topics: Bipolar Disorder; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Lithium | 2021 |
Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery.
Topics: Adult; Aged; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone | 2017 |
Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report.
Topics: Adenoma; Adult; Calcimimetic Agents; Cesarean Section; Cinacalcet; Female; Gestational Age; Humans; Hypercalcemia; Hyperthyroidism; Infant, Low Birth Weight; Infant, Newborn; Parathyroid Neoplasms; Pregnancy; Pregnancy Complications | 2018 |
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
Topics: Administration, Oral; Animals; Calcium; Cinacalcet; Disease Models, Animal; Ethylnitrosourea; Female; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Hypercalcemia; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Molecular; Mutation; Parathyroid Hormone; Receptors, Calcium-Sensing; Sequence Alignment; Sequence Analysis, DNA; Serum Albumin; Signal Transduction | 2017 |
Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
Topics: Adult; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Drug Administration Schedule; Female; Greece; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypophosphatemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Time Factors; Treatment Outcome | 2018 |
Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS.
Topics: Child; Cinacalcet; Clinical Trials as Topic; Drug Approval; Drug Industry; Drugs, Generic; Government Regulation; Humans; Hypercalcemia; Marketing; Patents as Topic; Pediatrics; United States; United States Food and Drug Administration | 2018 |
Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism.
Topics: Aged; Calcimimetic Agents; Calcium; Cinacalcet; Cross-Sectional Studies; Female; Gallstones; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Prevalence; Renal Dialysis; Sex Factors; Time Factors | 2018 |
Large-scale exome datasets reveal a new class of adaptor-related protein complex 2 sigma subunit (AP2σ) mutations, located at the interface with the AP2 alpha subunit, that impair calcium-sensing receptor signalling.
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex alpha Subunits; Adaptor Protein Complex sigma Subunits; Cinacalcet; Databases, Genetic; Exome; Exome Sequencing; Female; Humans; Hypercalcemia; Male; Middle Aged; Models, Molecular; Mutation; Protein Conformation; Receptors, Calcium-Sensing; Signal Transduction | 2018 |
A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic.
Topics: Aged, 80 and over; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Middle Aged; Parkinsonian Disorders | 2018 |
[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy].
Topics: Calcimimetic Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Parathyroid Glands; Parathyroid Hormone; Peptides; Receptors, Calcium-Sensing; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D | 2018 |
Acute pseudogout after cinacalcet treatment.
Topics: Acute Disease; Aged, 80 and over; Calcimimetic Agents; Calcium; Chondrocalcinosis; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary | 2018 |
Acute severe primary hyperparathyroidism: spontaneous remission after 2 years follow-up.
Topics: Calcium-Regulating Hormones and Agents; Cinacalcet; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Remission, Spontaneous; Renal Dialysis; Severity of Illness Index; Treatment Outcome | 2019 |
Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.
Topics: Aged, 80 and over; Allosteric Regulation; Autoantibodies; Autoantigens; Binding Sites; Calcium; Calcium-Regulating Hormones and Agents; Cinacalcet; HEK293 Cells; Humans; Hypercalcemia; Male; Receptors, Calcium-Sensing; Receptors, G-Protein-Coupled; Severity of Illness Index; Signal Transduction; Treatment Outcome | 2019 |
Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption.
Topics: Animals; Calcimimetic Agents; Calcium; Calcium Channels; Cinacalcet; Disease Models, Animal; Estrenes; Female; Gene Knock-In Techniques; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Intestinal Absorption; Intestinal Mucosa; Kidney Tubules; Male; Mice; Mice, Transgenic; Oocytes; Parathyroid Hormone; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyrrolidinones; Receptors, Calcium-Sensing; TRPV Cation Channels; Type C Phospholipases; Xenopus | 2019 |
Effectiveness and safety of cinacalcet for primary hyperparathyroidism: a single center experience.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Nausea; Retrospective Studies; Treatment Outcome | 2019 |
Effect of Cinacalcet in Kidney Transplant Patients With Hyperparathyroidism.
Topics: Adult; Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Retrospective Studies | 2019 |
Cinacalcet effect on polymorphonuclear leucocytes of kidney transplant patients.
Topics: Apoptosis; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Neutrophils; Phagocytosis; Respiratory Burst | 2013 |
Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.
Topics: Animals; Calcitonin; Calcium; Cell Line, Tumor; Cinacalcet; Colonic Neoplasms; Female; Gene Expression Regulation; Hypercalcemia; Leydig Cell Tumor; Male; Mice; Naphthalenes; Parathyroid Hormone-Related Protein; Rats; Receptors, Calcium-Sensing | 2013 |
Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet.
Topics: Calcimimetic Agents; Cinacalcet; DNA Mutational Analysis; Drug Resistance; Exons; Genetic Predisposition to Disease; Homozygote; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthalenes; Phenotype; Receptors, Calcium-Sensing; Sequence Deletion; Treatment Failure | 2013 |
Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Cinacalcet; Diphosphonates; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Ibandronic Acid; Naphthalenes; Osteoporosis; Parathyroid Hormone; Phosphates; Vitamin D | 2013 |
Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study.
Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Retrospective Studies | 2014 |
Renal replacement therapy as a treatment for severe refractory hypercalcemia.
Topics: Adenoma; Adult; Carcinoma; Cinacalcet; Diphosphonates; Drug Resistance; Emergencies; Female; Furosemide; Hemodiafiltration; Hemofiltration; Humans; Hydroxycholecalciferols; Hypercalcemia; Hypoparathyroidism; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Naphthalenes; Pamidronate; Pancreatitis, Acute Necrotizing; Parathyroid Neoplasms; Parathyroidectomy | 2014 |
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication.
Topics: Adult; Bone Density; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Parathyroid Hormone; Treatment Outcome | 2015 |
Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation.
Topics: Adult; Aged; Bone and Bones; Calcimimetic Agents; Calcium; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hypophosphatemia; Kidney Transplantation; Male; Middle Aged; Phosphates; Prospective Studies | 2015 |
A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
Topics: Adult; Aged; Blotting, Western; Calcimimetic Agents; Cinacalcet; Genetic Markers; Humans; Hypercalcemia; Hypercalciuria; Male; Naphthalenes; Parathyroid Hormone; Pedigree; Point Mutation; Receptors, Calcium-Sensing; Treatment Outcome | 2014 |
[Primary hyperparathyroidism: new concepts, new recommendations].
Topics: Adult; Aged; Bone Density; Calcium; Cinacalcet; Diphosphonates; Endocrinology; Fractures, Bone; General Surgery; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant; Infant, Newborn; Lithiasis; Middle Aged; Naphthalenes; Nephrocalcinosis; Practice Guidelines as Topic; Risk Factors; Societies, Medical; Vitamin D Deficiency | 2014 |
Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation.
Topics: Calcium; Cinacalcet; Female; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism; Kidney; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies | 2015 |
Cinacalcet Treatment in an Adolescent With Concurrent 22q11.2 Deletion Syndrome and Familial Hypocalciuric Hypercalcemia Type 3 Caused by AP2S1 Mutation.
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Adolescent; Base Sequence; Cinacalcet; DiGeorge Syndrome; Humans; Hypercalcemia; Male; Mutation, Missense; Naphthalenes; Pedigree | 2015 |
Parathyroidectomy or Calcimimetic to Treat Hypercalcemia after Kidney Transplantation?
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Kidney Transplantation; Parathyroid Hormone; Parathyroidectomy | 2016 |
Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Topics: Allosteric Regulation; Amino Acid Substitution; Cinacalcet; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Hypercalcemia; Hypocalcemia; Mutation, Missense; Naphthalenes; Receptors, Calcium-Sensing; Signal Transduction | 2016 |
Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations.
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex sigma Subunits; Adult; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Male; Middle Aged; Mutation | 2016 |
Treatment of Persistent Hypercalcemia and Hyperparathyroidism With Cinacalcet After Successful Kidney Transplantation.
Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies | 2016 |
Hyperparathyroidism-jaw Tumor Syndrome: An Overlooked Cause of Severe Hypercalcemia.
Topics: Adenoma; Adult; Calcimimetic Agents; Calcitonin; Calcium; Cinacalcet; Diagnosis, Differential; Female; Fibroma; Humans; Hypercalcemia; Hyperparathyroidism; Jaw Neoplasms; Parathyroid Hormone; Parathyroidectomy; Treatment Outcome | 2016 |
Natural History of Serum Calcium and Parathyroid Hormone Following Renal Transplantation.
Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Retrospective Studies | 2016 |
Use of cinacalcet HCl to achieve the recommended targets of bone metabolism in a patient with therapy-resistant renal hyperparathyroidism.
Topics: Adult; Bone Diseases, Metabolic; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Treatment Outcome; Weight Gain | 2008 |
Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose.
Topics: Adult; Aged; Calcium; Cinacalcet; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Tacrolimus | 2008 |
Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.
Topics: Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Liver Cirrhosis; Middle Aged; Naphthalenes; Parathyroid Neoplasms; Ultrasonography | 2009 |
A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet.
Topics: Administration, Oral; Bone Density Conservation Agents; Cinacalcet; Familial Hypophosphatemic Rickets; Female; Genetic Diseases, X-Linked; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism; Hypertension; Infant; Mutation, Missense; Naphthalenes; Nephrocalcinosis; PHEX Phosphate Regulating Neutral Endopeptidase; Phosphates; Renal Insufficiency | 2008 |
Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.
Topics: Adult; Aged; Calcium; Cinacalcet; Female; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Postoperative Complications | 2008 |
[Primary hyperparathyroidism. An alternative to the surgery].
Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid | 2009 |
Cinacalcet for hyperparathyroidism in pregnancy and puerperium.
Topics: Adult; Calcitonin; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Male; Naphthalenes; Postpartum Period; Pregnancy; Pregnancy Complications; Treatment Outcome | 2009 |
Is it my calcium, Doctor?
Topics: Calcium; Child; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Kidney Calculi; Naphthalenes; Parathyroid Hormone; Renal Colic; Ultrasonography | 2009 |
Parathyroid gland: cinacalcet-can it control hypercalcemia?
Topics: Cinacalcet; DNA; Humans; Hypercalcemia; Hyperparathyroidism; Naphthalenes; Receptors, Calcium-Sensing | 2010 |
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Topics: Attitude of Health Personnel; Biomarkers; Bone Diseases, Metabolic; Calcium; Chelating Agents; Chronic Disease; Cinacalcet; Evidence-Based Medicine; Glomerular Filtration Rate; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Saudi Arabia; Surveys and Questionnaires; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2010 |
[Patient with chronic kidney disease and primary or tertiary hyperparathyroidism--case report].
Topics: Adult; Chronic Disease; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Diseases; Naphthalenes | 2009 |
Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism.
Topics: Aged, 80 and over; Biomimetic Materials; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Naphthalenes; Parathyroid Neoplasms; Receptors, Calcium-Sensing | 2010 |
Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia.
Topics: Biomarkers; Calcium; Child; Cinacalcet; Genetic Predisposition to Disease; Humans; Hypercalcemia; Male; Mutation; Naphthalenes; Parathyroid Hormone; Pedigree; Receptors, Calcium-Sensing; Time Factors; Treatment Outcome; Tympanoplasty; Wound Healing | 2010 |
Evaluation of cinacalcet HCl treatment after kidney transplantation.
Topics: Adult; Bone and Bones; Cinacalcet; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Patient Selection; Postoperative Complications; Retrospective Studies | 2010 |
Continuation of cinacalcet immediately after renal transplantation: a prospective cohort study.
Topics: Adult; Biomarkers; Calcimimetic Agents; Calcium; Case-Control Studies; Chi-Square Distribution; Cinacalcet; Drug Administration Schedule; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Netherlands; Parathyroid Hormone; Phosphates; Prospective Studies; Time Factors; Treatment Outcome | 2010 |
Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism.
Topics: Absorptiometry, Photon; Adult; Arm Bones; Biomarkers; Bone Density; Calcimimetic Agents; Calcium; Case-Control Studies; Cinacalcet; Female; Hip Joint; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; National Institutes of Health (U.S.); Retrospective Studies; Spine; Time Factors; Treatment Outcome; United States | 2010 |
Cinacalcet in the treatment of hypercalcaemia and control of hyperparathyroidism due to ectopic parathyroid glands.
Topics: Aged, 80 and over; Calcimimetic Agents; Calcitriol; Choristoma; Cinacalcet; Female; Gastrointestinal Diseases; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Mediastinal Diseases; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2011 |
Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Cinacalcet; Drug Therapy, Combination; Female; Femur; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Lumbar Vertebrae; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Retrospective Studies | 2011 |
[Cinacalcet impact on calcium homeostasis and bone remodeling in 13 renal transplanted patients with hyperparathyroidism and hypercalcaemia].
Topics: Adult; Aged; Bone Remodeling; Calcium; Cinacalcet; Female; Homeostasis; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Prospective Studies | 2012 |
[The value of selective parathyroid venous sampling for localizing occult parathyroid adenomas].
Topics: Adenoma; Aged; Blood Specimen Collection; Catheterization, Peripheral; Cinacalcet; False Negative Reactions; Female; Goiter, Nodular; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Magnetic Resonance Imaging; Naphthalenes; Neoplasm Recurrence, Local; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Preoperative Care; Radionuclide Imaging; Reoperation; Thyroidectomy; Veins; Vitamin D Deficiency | 2012 |
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling.
Topics: Aged; Aged, 80 and over; Biomarkers; Cinacalcet; Contraindications; Drug Labeling; European Union; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Maintenance Chemotherapy; Membrane Transport Modulators; Middle Aged; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Parathyroidectomy; Practice Guidelines as Topic; Prospective Studies; Receptors, Calcium-Sensing; Severity of Illness Index | 2012 |
Antilipolytic effect of calcimimetics depends on the allelic variant of calcium-sensing receptor gene polymorphism rs1042636 (Arg990Gly).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Calcium; Cinacalcet; Genetic Variation; Humans; Hypercalcemia; Middle Aged; Naphthalenes; Polymorphism, Genetic; Receptors, Calcium-Sensing | 2012 |
[Long-term combined treatment with cinacalcet and bisphosphonates in persistent primary hyperparathyroidism after surgery].
Topics: Alendronate; Bone Density Conservation Agents; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hypercalciuria; Hyperparathyroidism, Primary; Hyperphosphatemia; Middle Aged; Naphthalenes; Osteoporosis; Postoperative Complications | 2012 |
Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes | 2012 |
Short-term use of cinacalcet in children on regular hemodialysis.
Topics: Adolescent; Calcimimetic Agents; Child; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic | 2012 |
Cinacalcet for management of hypercalcemia secondary to calcium-sensing receptor mutation.
Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Mutation; Naphthalenes; Receptors, Calcium-Sensing | 2013 |
Management of lithium-associated hyperparathyroidism.
Topics: Bipolar Disorder; Calcimimetic Agents; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Lithium; Middle Aged; Naphthalenes; Parathyroidectomy; Postoperative Complications | 2012 |
Cognitive decline reversed by cinacalcet.
Topics: Aged, 80 and over; Calcimimetic Agents; Cinacalcet; Cognition Disorders; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes | 2015 |
Cinacalcet to prevent parathyrotoxic crises in hypercalcaemic patients awaiting parathyroidectomy.
Topics: Adenoma; Adult; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; Middle Aged; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy | 2011 |
Hyperparathyroidism in chronic kidney disease: complexities within the commonplace.
Topics: Adult; Aged; Cinacalcet; Comorbidity; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Renal Insufficiency, Chronic | 2012 |
Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
Topics: Adult; Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Creatinine; Drug Administration Schedule; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Time Factors; Treatment Outcome | 2012 |
Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
Topics: Alkaline Phosphatase; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia.
Topics: Adult; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Male; Naphthalenes; Severity of Illness Index; Treatment Failure | 2005 |
Therapeutic failure of cinacalcet in a renal transplant patient.
Topics: Cinacalcet; Drug Resistance; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Naphthalenes; Parathyroidectomy; Treatment Failure | 2006 |
Looking at calcimimetics impact on hypercalcemia of immobilization: hypotheses and a case study.
Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immobilization; Naphthalenes; Receptors, Calcium-Sensing | 2006 |
Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.
Topics: Aged; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Receptors, Calcium-Sensing | 2006 |
Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.
Topics: Administration, Oral; Alkaline Phosphatase; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor.
Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Humans; Hypercalcemia; Male; Mutation, Missense; Naphthalenes; Parathyroid Hormone; Receptors, Calcium-Sensing; Time Factors | 2006 |
A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy.
Topics: Adenocarcinoma; Alcohol Drinking; Biopsy, Fine-Needle; Calcitriol; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Liver Neoplasms; Male; Middle Aged; Naphthalenes; Neck; Neoplasm Metastasis; Parathyroid Hormone; Parathyroid Neoplasms; Radiography; Ultrasonography | 2006 |
Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride.
Topics: Aged; Antimanic Agents; Bipolar Disorder; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Lithium Carbonate; Middle Aged; Naphthalenes; Parathyroid Hormone | 2006 |
Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCl.
Topics: Adolescent; Calcium; Cinacalcet; Diagnosis, Differential; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus | 2006 |
Lithium hypercalcemia, hyperparathyroidism, and cinacalcet.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Lithium Compounds; Naphthalenes; Parathyroid Hormone; Phosphates; Serum Albumin; Treatment Outcome | 2007 |
Cinacalcet-associated cardiogenic shock in a patient with cardiomyopathy.
Topics: Calcium; Cardiomyopathies; Cardiotonic Agents; Cinacalcet; Drug Administration Schedule; Heart Failure; Hemofiltration; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Probability; Shock, Cardiogenic | 2007 |
Improvement in hypercalcemia with cinacalcet after kidney transplantation.
Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Retrospective Studies | 2006 |
Correction of hypercalcaemia by cinacalcet in familial hypocalciuric hypercalcaemia.
Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Naphthalenes | 2008 |